Use of BCG in Immunotherapy of Superficial Bladder Cancer: Multicentric Investigation on Safety and Compliance

Author： Morgia Giuseppe Falsaperla Mario Madonia Massimo Vacirca Franco La Pira Giuseppe De Grande Gaetano Nicololosi Dario Raciti Giovanni Capizzi Giuseppe Serrao Antonio Torrisi Benedetto

Publisher： Ashgate Publishing Ltd

ISSN： 1561-0950

Source： UroOncology, Vol.2, Iss.3, 2003-07, pp. : 129-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Outcome and Safety of Bacillus Calmette-Guérin Immunotherapy for Superficial Bladder Cancer

By Morabito F. Volpe A. Rossi R. Lasaponara F. Ferrando U.

UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. : 145-150

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical Outcome and Safety of Bacillus Calmette-Guérin Immunotherapy for Superficial Bladder Cancer

By Morabito F. Volpe A. Rossi R. Lasaponara F. Ferrando U.

UroOncology, Vol. 4, Iss. 2, 2004-06 ,pp. : 97-102

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Treatment of High Grade Superficial Bladder Cancer and Carcinoma In Situ with BCG -- A Questionnaire Survey of Consultant Practice in England and Wales

By Meyer Jon-Paul Persad Rajendra Probert John L. Gillatt David A.

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 77-80

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Epirubicin: A Review of its Intravesical Use in Superficial Bladder Cancer

By Onrust S.V. Wiseman L.R. Goa K.L.

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 307-333

Adis International

Access to resources Recommend Favorite

Immunotherapy in Bladder Cancer

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-09 ,pp. : 242-251

Bentham Science Publishers

Access to resources Recommend Favorite